IN190017B - - Google Patents

Info

Publication number
IN190017B
IN190017B IN141DE1999A IN190017B IN 190017 B IN190017 B IN 190017B IN 141DE1999 A IN141DE1999 A IN 141DE1999A IN 190017 B IN190017 B IN 190017B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Amarjit Singh
Rajesh Jain
Original Assignee
Panacea Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotech Ltd filed Critical Panacea Biotech Ltd
Priority to IN141DE1999 priority Critical patent/IN190017B/en
Priority to JP2000594444A priority patent/JP2002535266A/ja
Priority to AU33221/00A priority patent/AU3322100A/en
Priority to EP00982737A priority patent/EP1105097A2/en
Priority to BR0004813-5A priority patent/BR0004813A/pt
Priority to PCT/IN2000/000004 priority patent/WO2000042987A2/en
Priority to RU2000126759/14A priority patent/RU2207113C2/ru
Priority to US09/490,127 priority patent/US6306838B1/en
Publication of IN190017B publication Critical patent/IN190017B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN141DE1999 1999-01-25 1999-01-25 IN190017B (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IN141DE1999 IN190017B (ja) 1999-01-25 1999-01-25
JP2000594444A JP2002535266A (ja) 1999-01-25 2000-01-24 細胞保護およびＨ．ｐｙｌｏｒｉ感染の処置のための標的化小胞構築物
AU33221/00A AU3322100A (en) 1999-01-25 2000-01-24 Targeted vesicular constructs for cytoprotection and treatment of (h. pylori) infections
EP00982737A EP1105097A2 (en) 1999-01-25 2000-01-24 Targeted vesicular constructs for cytoprotection and treatment of h.pylori infections
BR0004813-5A BR0004813A (pt) 1999-01-25 2000-01-24 Constructos vesiculares marcados para citoproteção e tratamento de infecções por h. pylori
PCT/IN2000/000004 WO2000042987A2 (en) 1999-01-25 2000-01-24 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections
RU2000126759/14A RU2207113C2 (ru) 1999-01-25 2000-01-24 Целевые везикулярные конструкции для защиты клетки и для лечения инфекций h. pylori
US09/490,127 US6306838B1 (en) 1999-01-25 2000-01-24 Targeted vesicular constructs for cyto protection and treatment of h. pylori

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN141DE1999 IN190017B (ja) 1999-01-25 1999-01-25

Publications (1)

Publication Number Publication Date
IN190017B true IN190017B (ja) 2003-05-31

Family

ID=11088428

Family Applications (1)

Application Number Title Priority Date Filing Date
IN141DE1999 IN190017B (ja) 1999-01-25 1999-01-25

Country Status (8)

Country Link
US (1) US6306838B1 (ja)
EP (1) EP1105097A2 (ja)
JP (1) JP2002535266A (ja)
AU (1) AU3322100A (ja)
BR (1) BR0004813A (ja)
IN (1) IN190017B (ja)
RU (1) RU2207113C2 (ja)
WO (1) WO2000042987A2 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02009587A (es) * 2000-03-28 2003-05-14 Biochemie Gmbh Particulas granuladas con sabor enmascarado.
US6576625B2 (en) * 2001-03-16 2003-06-10 Panacea Biotic Limited Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections
EP1350507A1 (en) * 2002-04-04 2003-10-08 Applied NanoSystems B.V. Delivery of a substance to a pre-determinated site
US20070042184A1 (en) 2003-08-22 2007-02-22 Danisco A/S Microcapsules
GB2388581A (en) 2003-08-22 2003-11-19 Danisco Coated aqueous beads
WO2006015423A1 (en) * 2004-08-11 2006-02-16 Clifford C Holloway Method and apparatus for collection and treatment of encapsulated waste
US20180177725A1 (en) * 2015-09-10 2018-06-28 Washington State University Cell membrane-formed nanoscale vesicles and methods of using thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
AU652778B2 (en) * 1990-10-15 1994-09-08 Quest International B.V. Treatment composition
US5478819A (en) * 1993-06-23 1995-12-26 Simo Tarpila Phospholipid composition and use thereof
ES2121293T3 (es) 1994-04-07 1998-11-16 Pfizer Uso de trovafloxacina o derivados de la misma para la fabricacion de un medicamento para el tratamiento de infecciones por h. pylori.
GB9407869D0 (en) 1994-04-20 1994-06-15 Caduceus Ltd Antimicrobial compounds
FR2718965B1 (fr) 1994-04-25 1996-05-24 Rhone Poulenc Rorer Sa Nouvelle application thérapeutique de la spiramycine.
WO1995031199A1 (en) 1994-05-11 1995-11-23 P.N. Gerolymatos S.A. Use of clioquinol for treating helicobacter, including h. pylori, infections and related diseases
GB9505032D0 (en) * 1995-03-13 1995-05-03 Westminster Lab Ltd Improvements in or relating to organic compositions
WO1996024368A1 (en) * 1995-02-07 1996-08-15 Lectin Biopharma, Inc. Method of using lectins for prevention and treatment of oral and alimentary tract disorders
AU4596796A (en) 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with bismuth and antibacterials

Also Published As

Publication number Publication date
BR0004813A (pt) 2000-11-21
WO2000042987A3 (en) 2000-11-02
EP1105097A2 (en) 2001-06-13
WO2000042987A8 (en) 2001-06-28
JP2002535266A (ja) 2002-10-22
AU3322100A (en) 2000-08-07
US6306838B1 (en) 2001-10-23
RU2207113C2 (ru) 2003-06-27
WO2000042987A2 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
BE2018C020I2 (ja)
BE2015C057I2 (ja)
BE2016C007I2 (ja)
BE2015C018I2 (ja)
BE2014C017I2 (ja)
BE2013C051I2 (ja)
BE2013C020I2 (ja)
BE2013C015I2 (ja)
BE2013C001I2 (ja)
BE2012C036I2 (ja)
BE2011C004I2 (ja)
BE2010C011I2 (ja)
BE2008C046I2 (ja)
BE1025464I2 (ja)
BRPI0017527B8 (ja)
BE2008C047I2 (ja)
BRPI0001672A2 (ja)
JP2002502672A5 (ja)
BRPI0001542A2 (ja)
IN189334B (ja)
BRPI0012675B8 (ja)
BRPI0017522A2 (ja)
JP2000103090A5 (ja)
IN185090B (ja)
ECSDI990569S (ja)